Key facts
- This page summarizes Leonard E. Post's Form 4 filing for CG Oncology, Inc. (CGON).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Jan 2025, 16:16.
Leonard E. Post - 13 Jan 2025 Form 4 Insider Report for CG Oncology, Inc. (CGON)
- Reporting relationship
- Director
- Issuer ticker
- CGON
- Reported as of
- 13 Jan 2025
- Net transaction value
- -$29,060
- SEC form
- 4
- Accepted by SEC
- 14 Jan 2025, 16:16:52 UTC
- Prior SEC filing
- 17 Dec 2024
- Next SEC filing
- 19 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua F. Patterson, Attorney-in-Fact for Leonard Post
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Leonard E. Post filed Form 4 for CG Oncology, Inc. (CGON) on 14 Jan 2025.
Change
- Previous filing in this sequence was filed on 17 Dec 2024.
- Current net transaction value: -$29,060.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CGON
transaction
Common Stock
Options Exercise
- Transaction value
- $600
- Shares
- +1,000
- Change %
- Price
- $0.6000
- Shares after
- 1,000
- Date
- 13 Jan 2025
- Ownership
- Direct
CGON
transaction
Common Stock
Sale
- Transaction value
- $29,660
- Shares
- -1,000
- Change %
- -100%
- Price
- $29.66
- Shares after
- 0
- Date
- 13 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CGON
transaction
Derivative
Director Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,000
- Change %
- -0.75%
- Price
- $0.000000
- Shares after
- 132,077
- Date
- 13 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000
- Exercise price
- $0.6000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024.
Footnote F2
Fully vested